Fox Chase Cancer Center Pancreatic Cancer Researcher Receives American Cancer Society Research Grant

PHILADELPHIA (December 13, 2018) – The American Cancer Society’s newly formed Pennsylvania/New Jersey Pay-If Research Council has selected Jaye Gardiner, PhD, from Fox Chase Cancer Center, to receive a $163,500 research grant to study ways to identify better treatment options for pancreatic cancer patients.

Thanks to the efforts of the Pay-If Research Council, Gardiner will continue her efforts to understand the signaling that arises from cell-cell interactions in the pancreatic tumor microenvironment.

“We are excited by the possibilities that Dr. Gardiner’s research presents,” said Arnold Baskies, MD, Pennsylvania/New Jersey Pay-If Research Council Co-Chair and American Cancer Society Past Chairman of the National Board of Directors.

“This year, over 55,000 people will be diagnosed with pancreatic cancer, and over 44,000 will die. This is incredibly important work, as it will help us to understand the underlying cause of pancreatic cancer.”

The American Cancer Society Pennsylvania/New Jersey Pay-If Council research grant was made possible by the efforts of its members, comprised of generous donors, volunteers and community leaders from across the Greater Philadelphia area. The committee’s role is to spread visibility and help raise additional funds to support pay-if research grants with a goal of dramatically reducing unnecessary suffering and death from cancer.

Gardiner studies pancreatic cancers as a member of the Edna Cukierman laboratory at Fox Chase. Her research seeks to understand how and why a cancer cell’s environment influences whether it will grow, spread, or respond to treatment. Gardiner recently won the Science Communication Prize from the Mindlin Foundation, and was a semi-finalist for the HHMI Hanna H. Gray Fellows Award.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427